Consequently, these findings strongly suggest that the ERK1/2-c-Myc pathway leads to nuclear localization of the p21 protein, a suppressor of cell growth, and plays a pivotal direct role in butyrate’s inhibitory efficacy against colon cancer proliferation. Here, CDKN1A is linked to malignant colon neoplasm.